SB-681323

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for SB-681323, covering 2012-06-04 to 2017-10-18. Get the full timeline:

Most recent: Clinical Trial Update: SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS [Phase 2]